Complex Regional Pain Syndrome (CRPS) was recently designated as a rare disorder by the United States Food & Drug Administration. A disease is considered rare if fewer than 200,000 people in the United States have it. This designation has already generated much greater interest than ever before in CRPS/RSD and is enticing pharmaceutical corporations to consider developing medicines to treat CRPS.
Clinical trials in CRPS which are recruiting right now
- A Clinical Trail of The Evoke, a closed loop Spinal Cord System.
To learn more about the ECAP Clinical Study and to see if you might qualify, please visit ecapstudy.com
- RSDSA is funding a clinical trial at The Cleveland Clinic to determine whether nitrous oxide would be effective in treating pain caused by CRPS
- To locate clinical trials in CRPS and RSD, visit clinicaltrials.gov
- RSDSA has ended its 20-year study of the long-term health impact of CRPS on individuals diagnosed with it. We thank everyone who participated. We have begun the analysis of the data and hope to publish the results as soon as possible.